Robotics and artificial intelligence in healthcare during COVID-19 pandemic: A systematic review

S Sarker, L Jamal, SF Ahmed, N Irtisam - Robotics and autonomous …, 2021 - Elsevier
The outbreak of the COVID-19 pandemic is unarguably the biggest catastrophe of the 21st
century, probably the most significant global crisis after the second world war. The rapid …

Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods

C Choudhury, NA Murugan, UD Priyakumar - Drug discovery today, 2022 - Elsevier
Highlights•Repurposing existing drugs for new diseases is cost effective and time saving.•In
silico methods are crucial for rapid drug screening in the early stages.•Machine learning …

[HTML][HTML] DrugRep: an automatic virtual screening server for drug repurposing

J Gan, J Liu, Y Liu, S Chen, W Dai, ZX Xiao… - Acta Pharmacologica …, 2023 - nature.com
Computationally identifying new targets for existing drugs has drawn much attention in drug
repurposing due to its advantages over de novo drugs, including low risk, low costs, and …

A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2

X Su, L Hu, Z You, P Hu, L Wang… - Briefings in …, 2022 - academic.oup.com
The outbreak of COVID-19 caused by SARS-coronavirus (CoV)-2 has made millions of
deaths since 2019. Although a variety of computational methods have been proposed to …

VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares

L Shen, F Liu, L Huang, G Liu, L Zhou… - Computers in biology and …, 2022 - Elsevier
Background A new coronavirus disease named COVID-19, caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), is rapidly spreading worldwide …

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection

CS Dampalla, J Zheng, KD Perera… - Proceedings of the …, 2021 - National Acad Sciences
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection continues to be a
serious global public health threat. The 3C-like protease (3CLpro) is a virus protease …

Haste makes waste: a critical review of docking‐based virtual screening in drug repurposing for SARS‐CoV‐2 main protease (M‐pro) inhibition

G Macip, P Garcia‐Segura… - Medicinal Research …, 2022 - Wiley Online Library
This review makes a critical evaluation of 61 peer‐reviewed manuscripts that use a docking
step in a virtual screening (VS) protocol to predict SARS‐CoV‐2 M‐pro (M‐pro) inhibitors in …

Accelerating COVID-19 research using molecular dynamics simulation

AK Padhi, SL Rath, T Tripathi - The Journal of Physical Chemistry …, 2021 - ACS Publications
The COVID-19 pandemic has emerged as a global medico-socio-economic disaster. Given
the lack of effective therapeutics against SARS-CoV-2, scientists are racing to disseminate …

[HTML][HTML] The impact of D614G mutation of SARS-COV-2 on the efficacy of anti-viral drugs: A comparative molecular docking and molecular dynamics study

A Poustforoosh, H Hashemipour, B Tüzün… - Current …, 2022 - Springer
D614G is one of the most reported mutations in the spike protein of SARS-COV-2 that has
altered some crucial characteristics of coronaviruses, such as rate of infection and binding …

Molecular docking: principles, advances, and its applications in drug discovery

MT Muhammed, E Aki-Yalcin - Letters in Drug Design & …, 2024 - ingentaconnect.com
Molecular docking is a structure-based computational method that generates the binding
pose and affinity between ligands and targets. There are many powerful docking programs …